Doug Hampton 
Starts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow’s business, focus on near-term revenue generation and reduce cash burn are paying off MOUNTAIN VIEW, Calif., May 11, 2023 /PRNewswire/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), a leading … Read more
DUBLIN, May 11, 2023 /PRNewswire/ — The “Global Cystic Fibrosis Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global cystic fibrosis treatment market size was valued at USD 8.3 billion in 2022 and is projected to grow at a CAGR of 13.4% during the forecast period of 2023-2031 to reach … Read more
DUBLIN , May 11, 2023 /PRNewswire/ — The “Advanced Pharmacovigilance Training Course” conference has been added to ResearchAndMarkets.com’s offering. Pharmacovigilance has undergone rapid regulatory change in recent years, which has resulted in a complex range of safety and risk assessment activities to perform. This three-day course is designed for those with at least two years of knowledge … Read more
Dublin, May 11, 2023 /PRNewswire/ — The “Global Stem Cell Partnering Terms and Agreements 2010-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Stem Cell Partnering Terms and Agreements 2010-2023 report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies. Trends … Read more
DUBLIN, May 11, 2023 /PRNewswire/ — The “Global Antibody Partnering Terms and Agreements 2016-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Antibody Partnering Terms and Agreements 2016 to 2023 report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides … Read more
DUBLIN, May 11, 2023 /PRNewswire/ — The “Global Hospital-Acquired Infection Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global hospital-acquired infection treatment market size was valued at USD 15.31 billion in 2022 and is projected to grow at a CAGR of 4.2% during the forecast period of 2023-2031 to … Read more
SHANGHAI, May 11, 2023 /PRNewswire/ — An imported version of Nefecon (budesonide) delayed release capsule has been added to the 2023 New Reimbursement Drug List of Specialized Medicines of the “Beijing Puhui Health Insurance Program.” Nefecon is a first-in-disease treatment for adults with primary immunoglobulin A nephropathy (IgAN). Nefecon has been approved by the United States Food … Read more
In English SILVER SPRING, Md., 11 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) otorgó la aprobación complementaria para los comprimidos orales de Rexulti (brexpiprazol) para el tratamiento de la agitación asociada con la demencia debido a la enfermedad de Alzheimer. … Read more
In English SILVER SPRING, Md., 11 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) finalizó las recomendaciones para evaluar la elegibilidad de los donantes de sangre mediante un conjunto de preguntas individuales basadas en el riesgo para reducir el riesgo … Read more
CONCORD, N.H., May 11, 2023 /PRNewswire/ — The New Hampshire Department of Health and Human Services (DHHS) has determined that a laboratory error incorrectly caused last week’s recall announcement concerning lēf Farms “Spice” Packaged Salad Greens. The products from lēf Farms are safe and the recall has been canceled. On May 5, a press release … Read more